CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 167 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2014. The put-call ratio across all filers is 2.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $89,000 | +64.8% | 177,115 | +839.3% | 0.00% | – |
| Q4 2017 | $54,000 | +68.8% | 18,857 | +66.3% | 0.00% | – |
| Q3 2017 | $32,000 | -25.6% | 11,336 | +5.7% | 0.00% | – |
| Q3 2016 | $43,000 | -71.7% | 10,723 | -73.3% | 0.00% | -100.0% |
| Q1 2016 | $152,000 | -95.3% | 40,161 | -80.5% | 0.00% | -95.0% |
| Q4 2015 | $3,233,000 | +593.8% | 206,213 | +1015.6% | 0.02% | +566.7% |
| Q2 2015 | $466,000 | -68.5% | 18,484 | -65.2% | 0.00% | -72.7% |
| Q1 2015 | $1,479,000 | +259.0% | 53,041 | +135.0% | 0.01% | +266.7% |
| Q4 2014 | $412,000 | – | 22,570 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |